GlassScriptPhysician profile
Frances Mae West
NPI 1750608790
$14,141.50
in general payments reported to CMS, 2019-2025
20 companies · $1,546 in 2025
The $1,546 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $1,619 · 2021: $375 · 2022: $372 · 2023: $3,674 · 2024: $6,435 · 2025: $1,546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $3,500 · Consulting Fee: $3,164 · Food and Beverage: $2,941 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Gift: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $3,500.00 |
| Consulting Fee | $3,164.00 |
| Food and Beverage | $2,940.87 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Gift | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $3,958.65 | 2021-2025 | Indigo System |
| Exo Imaging, INC. | $3,550.00 | 2024 | Exo Iris |
| Inari Medical, INC. | $3,497.35 | 2019-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Fujifilm Sonosite, INC. | $1,619.15 | 2020 | |
| Mindray Ds USA, INC. | $218.66 | 2023-2025 | Te X, Te7 Max |
| Innova Vascular INC. | $159.87 | 2024 | |
| Boston Scientific Corporation | $156.33 | 2025 | Ekosonic |
| Philips North America LLC | $143.99 | 2024 | (Bv6) 5500 Whc and Poc Ultrasound System |
| Glaxosmithkline, LLC. | $134.45 | 2022-2025 | Trelegy Ellipta |
| Genzyme Corporation | $117.04 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $114.92 | 2023-2024 | Dupixent |
| Ge Healthcare | $97.46 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.86 | 2024 | Ofev |
| Genentech USA, INC. | $81.44 | 2023-2025 | Xolair |
| Astrazeneca Pharmaceuticals LP | $75.19 | 2024-2025 | Fasenra |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $42.32 | 2023 | |
| Alexion Pharmaceuticals, INC. | $26.87 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.78 | 2024 | Aralast |
| Stryker Corporation | $17.39 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Electromed, INC. | $16.78 | 2023 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frances West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.